http://www.medcitynews.com/2010/01/enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine/?utm_source=rss&utm_medium=rss&utm_campaign=enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine MedCity News Sat, 11 Feb 2012 15:17:29 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.medcitynews.com/2010/01/enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine/comment-page-1/#comment-61377 EnteroMedics CEO: Don’t lump us in with failed Leptos Biomedical : MedCity News Thu, 18 Feb 2010 21:13:27 +0000 http://www.medcitynews.com/?p=18160#comment-61377 [...] the story, I wrote EnteroMedics’ problems with gaining FDA approval for its VBLOC therapy spelled bad news for companies like Leptos, who are far behind EnteroMedics in clinical [...] [...] the story, I wrote EnteroMedics’ problems with gaining FDA approval for its VBLOC therapy spelled bad news for companies like Leptos, who are far behind EnteroMedics in clinical [...]

]]> http://www.medcitynews.com/2010/01/enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine/comment-page-1/#comment-57644 Leptos Biomedical to call it quits : MedCity News Tue, 09 Feb 2010 23:35:04 +0000 http://www.medcitynews.com/?p=18160#comment-57644 [...] industry observers wondered if Leptos’ demise is related to EnteroMedics’ troubled clinical trials. Of all the companies developing neurostimulation devices to treat obesity, EnteroMedics was the [...] [...] industry observers wondered if Leptos’ demise is related to EnteroMedics’ troubled clinical trials. Of all the companies developing neurostimulation devices to treat obesity, EnteroMedics was the [...]

]]> http://www.medcitynews.com/2010/01/enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine/comment-page-1/#comment-55541 Night Read (Minnesota): EnteroMedics Inc. plans new clinical study on anti-obesity device : MedCity News Fri, 29 Jan 2010 03:47:16 +0000 http://www.medcitynews.com/?p=18160#comment-55541 [...] EnteroMedics Inc. of Roseville is planning to conduct an additional clinical study to determine whether its medical device effectively treats obesity, according to the Minneapolis-St. Paul Business Journal. After discussions with the U.S. Food and Drug Administration, EnteroMedics will apply for approval to conduct another human trial to supplement results from an earlier study, which showed the company’s Maestro’s device did not perform any better than the control group. [...] [...] EnteroMedics Inc. of Roseville is planning to conduct an additional clinical study to determine whether its medical device effectively treats obesity, according to the Minneapolis-St. Paul Business Journal. After discussions with the U.S. Food and Drug Administration, EnteroMedics will apply for approval to conduct another human trial to supplement results from an earlier study, which showed the company’s Maestro’s device did not perform any better than the control group. [...]

]]> http://www.medcitynews.com/2010/01/enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine/comment-page-1/#comment-53945 Night Read (Minnesota): Nasdaq gives EnteroMedics a little breathing room : MedCity News Sat, 23 Jan 2010 00:49:16 +0000 http://www.medcitynews.com/?p=18160#comment-53945 [...] a device to treat obesity with neurostimulation, has seen its stock plummet in recent months after it reported trouble with its clinical trials. Last November, Nasdaq threatened to delist EnteroMedics because its stock failed to trade above [...] [...] a device to treat obesity with neurostimulation, has seen its stock plummet in recent months after it reported trouble with its clinical trials. Last November, Nasdaq threatened to delist EnteroMedics because its stock failed to trade above [...]

]]> http://www.medcitynews.com/2010/01/enteromedics-inc-s-fate-now-in-the-hands-of-the-fda-your-guess-is-as-good-as-mine/comment-page-1/#comment-52374 Diagnostic Hybrids could add depth, innovation to Quidel’s line of diagnostic tests — MedCity Weekend Rounds, Jan. 16, 2010 : MedCity News Sat, 16 Jan 2010 18:36:30 +0000 http://www.medcitynews.com/?p=18160#comment-52374 [...] Minn., which is developing a device that uses electricity to treat obesity and diabetes, announced encouraging results from its latest clinical trial on Thursday. One major problem: EnteroMedics is a company dangling precariously from a cliff. Share and [...] [...] Minn., which is developing a device that uses electricity to treat obesity and diabetes, announced encouraging results from its latest clinical trial on Thursday. One major problem: EnteroMedics is a company dangling precariously from a cliff. Share and [...]

]]>